Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer

Clinical trial NCT04376073 · UNKNOWN

Trial details

NCT number: NCT04376073
Sponsor: Jihong Liu
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer

Start date: 2020-05-22
Primary completion: 2021-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.